Androgens can cause edema because they cause the kidneys to retain sodium.
And lets keep in mind corticosteroids do this as well. Ask anyone who is on methylprednisone.
sodium retention is just a posible consequence,there is states of water retention without sodium excess,hyponatremia that is euvolemic, hypervolemic or hypovolemic,there is a lot of process that produces excess vasopressin release,androgens that become estrogens by means of the aromatase,wr by progesterone,wr by estradiol,wr by prolactin etc.we are speaking about hyponatremia genesis,the fundamentals.
the underlying etiology is the vasopressin excess.
i have done cycles with low sodium and retain water anyway.
Med Sci Sports Exerc. 1990 Jun;22(3):331-40.
Glucocorticoid antagonism by exercise and androgenic-anabolic steroids.
Hickson RC, Czerwinski SM, Falduto MT, Young AP.
Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):487-95.
Effects of dehydroepiandrosterone on corticosterone release in rat zona fasciculata-reticularis cells.
Chang LL, Wun WS, Ho LL, Wang PS.
J Steroid Biochem. 1986 Feb;24(2):481-7.
Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle.
Danhaive PA, Rousseau GG
J Neuroendocrinol. 1996 Jun;8(6):439-47.
Androgens modulate glucocorticoid receptor mRNA, but not mineralocorticoid receptor mRNA levels, in the rat hippocampus.
Kerr JE, Beck SG, Handa RJ.
J Am Vet Med Assoc. 1993 Oct 15;203(8):1166-9.
Adrenal insufficiency associated with long-term anabolic steroid administration in a horse.
Dowling PM, Williams MA, Clark TP.
Eur J Endocrinol 2003 Jun; 148(6) :609-17.
Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases.
Diederich S, Franzen NF, Bähr V, Oelkers W .
N Engl J Med 1998; 321(8) :492-6.
Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism.
Oelkers, W.
Nippon Naika Gakkai Zasshi. 2006 May 10;95(5):936-8.
Hyponatremia associated with secondary adrenal insufficiency.
Kondo T, Mizubayashi R.
J Endocrinol Invest 2006 Mar; 29(3) :267-9.
Beyond semantics: defining hyponatremia in secondary adrenal insufficiency.
Faustini-Fustini M, Anagni M.
Am J Kidney Dis. 2006 May;47(5):727-37.
Vasopressin excess and hyponatremia.
Pham PC.
Am J Med. 2006 Jul;119(7 Suppl 1):S47-53.
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
Schrier RW.
Endocr Metab Immune Disord Drug Targets. 2006 Sep;6(3):249-58.
Vasopressin-receptor antagonists: a new class of agents for the treatment of hyponatremia.
Olson BR.
Endocrinology and Metabolism, 850 Straits Turnpike, Suite 204, Middlebury, CT 06762, USA.
Cleve Clin J Med. 2006 Sep;73 Suppl 3:S24-33. AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Verbalis JG.
Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA.
Tissue-specific expression patterns of nuclear receptors, 2006,NURSA.ORG
Bookout AL, Jeong Y, Downes M, Yu R, Evans RM and Mangelsdorf
Cell 126, 801-810, 2006.
Nuclear receptor expression links the circadian clock to metabolism.
Yang X, Downes M, Yu R, Bookout AL, He W, Straume M, Mangelsdorf DJ and Evans RM.
Nephrol Dial Transplant. 2001 Sep;16(9):1799-806.
Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema.
Park CW, Shin YS, Ahn SJ, Kim SY, Choi EJ, Chang YS, Bang BK.
ESTRADIOL RELATED:
Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E711-21.
Estrogen effects on osmotic regulation of AVP and fluid balance.
Stachenfeld NS, Keefe DL.
J Appl Physiol. 1999 Sep;87(3):1016-25. e
Effects of oral contraceptives on body fluid regulation.
........To test the hypothesis that estrogen reduces the operating point for osmoregulation of arginine vasopressin (AVP).......................
Stachenfeld NS, Silva C, Keefe DL, Kokoszka CA, Nadel ER.
Am J Physiol. 1998 Jan;274(1 Pt 2):R187-95.
Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women.
Stachenfeld NS, DiPietro L, Palter SF, Nadel ER.
J Appl Physiol. 2001 Oct;91(4):1893-901.
Sex differences in osmotic regulation of AVP and renal sodium handling.
Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP, Keefe DL.
PROGESTERONE AND PROLACTIN RELATED:
J Appl Physiol. 2005 Jun;98(6):1991-7.
Progesterone increases plasma volume independent of estradiol.
Stachenfeld NS, Taylor HS.
The John B. Pierce Laboratory, Yale University School of Medicine, 290 Congress Ave., New Haven, CT 06519, USA.
Neuroendocrinology. 1997 May;65(5):335-43.
RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys.
Pecins-Thompson M, Bethea CL.
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Beaverton 97006, USA.
Neuroendocrinology. 1996 Jun;63(6):569-78.
Beta-endorphin, but not oxytocin, substance P or vasoactive-intestinal polypeptide, contributes to progesterone-induced prolactin secretion in monkeys.
Pecins-Thompson M, Widmann AA, Bethea CL.
------------------------------------------
Principles And Practice Of Endocrinology And Metabolism
by John P. Bilezikian, et al.
Endocrinology and Metabolism
by Philip Felig, Lawrence A. Frohman
Williams Textbook of Endocrinology
by P. Reed Larsen, et al.
Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research : Proceedings of the 1st Joint World Congress of Neurohypophysis and (International Congress Series) by Japan Joint World Congress of Neurohypophysis and Vasopressin (1st : 1995 : Nasu-machi, Kiyoshi Kurokawa, Sho Yoshida, and Toshikazu Saito)
Vasopressin by G.J. Boer and D.M. Gash.
Vasopressin and Oxytocin: From Genes to Clinical Applications by D. Poulain, S. Oliet, and D. Theodosis, Oct 1, 2002.